If you have medullary thyroid cancer
HOPE is still an option.

The LIBRETTO thyroid cancer study may be an option for your medullary thyroid cancer.


I’m Interested Learn More

At a Glance

There is a need for safer, more effective medicines for medullary thyroid cancer (MTC). We are conducting a research study comparing the safety and effectiveness of the study drug, with the standard of care in the treatment of MTC. If you’re someone with MTC that has spread or gotten worse, you may be able to participate in this study.

Trial Details

  • Condition(s)
    Medullary thyroid cancer (MTC)
  • Potential Treatment Under Study
    An investigational medicine for MTC
Learn More

What's Involved

  • Maximum Trial Length
    Unlimited, if you choose
  • Appointments
    Every seven days
Learn More

Who Qualifies

  • Gender(s)
    Male & Female
  • Ages
    12+ or 18+,
    depending on location
Learn More

Locations

  • Countries
    About 17
  • Research Sites
    100+
Learn More

Are You Interested?

If you’re interested in participating in this research study, click the I’m Interested button. You will be taken to the Locations section where you can find a participating research site near you. You can use the site’s contact information to get in touch with someone at the research site for more information.

Why Participate

If you qualify, you’re the only person who can decide if participation is right for you. Each person and each research study are different. Every research study has risks and benefits for you to consider when deciding whether to participate.

People with MTC may want to take part in this study for the following reasons:

Explore Options

Possibly try a treatment that you previously have not.

Advance Medicine

Help research into new medicines move forward.

Become Involved

Take an active role in your healthcare decisions.